The CAR-T Landscape: Innovations, Challenges, and Future Directions
Join us for an insightful morning session on CAR-T Cell Therapy, designed for medical affairs professionals, with participation from regulatory and clinical experts. The session is followed by a networking lunch (12h00-13h00).
This session offers a comprehensive exploration of CAR-T therapy, tracing the journey of both cells and patients while unpacking its mechanisms of action and clinical applications. Participants will gain insights into current CAR-T treatments for hematologic and autoimmune diseases, as well as future directions including autologous and in vivo CAR-T pipelines. Diverse expert perspectives will highlight regulatory, market access, quality, healthcare provider, and industry considerations, culminating in a panel discussion on the key challenges hospitals and pharma face in production, regulation, and access. Together, these discussions provide a dynamic outlook on the impact and evolution of CAR-T therapies.
Program:
|
9:00-9:15 |
Introduction |
Ina Gesquiere Sarah Tavernier |
|
9:15-9:30 |
Patient testimonial |
|
|
9:30-10:35 |
CAR-T Therapy: From academic foundations to clinical breakthroughs |
Prof. Dr. Sébastien Anguille (UZA) |
|
10:35-10:50 |
BREAK |
|
|
10:50-11:20 |
Understanding the spectrum of CAR-T cell technologies |
|
|
11:20-12:20 |
Panel discussion: delving into CAR-T cell therapy challenges (regulatory, production, market access,...) |
|
|
12:20-12:30 |
Closing |
Ina Gesquiere Sarah Tavernier |
|
12:30 |
Networking lunch |
|
May we kindly ask you to help us in preparing this session and tailoring it to your needs, by letting us know which questions/topics you would like to see addressed during the panel debate. You can do so by filling out this form, which only takes 2 minutes of your time.